Chris Jewell
Net worth: - $ as of 2024-06-29
Profile
Chris Jewell is currently the Chief Scientific Officer at Cartesian Therapeutics, Inc. He started this position in 2023.
Prior to his current role, he was also the Chief Scientific Officer at Cartesian Therapeutics, Inc. from 2023 to 2023.
Additionally, Dr. Jewell worked as a Professor at the University of Maryland from 2012 to 2024.
He holds a doctorate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2024-04-17 | 0 ( -.--% ) | - $ | 2024-06-29 |
Chris Jewell active positions
| Companies | Position | Start |
|---|
Former positions of Chris Jewell
| Companies | Position | End |
|---|---|---|
| University of Maryland | Corporate Officer/Principal | 2024-03-31 |
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2023-11-12 |
Training of Chris Jewell
| University of Wisconsin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
- Stock Market
- Insiders
- Chris Jewell
